| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |